Applications of four kaurane diterpene compounds in preparation of glycosidase inhibitor medicines
A glycosidase inhibitor, kaurine-type technology is applied to the application field of four kaurine diterpenoid compounds in the preparation of glycosidase inhibitor drugs, and the preparation process is easy to operate, high in safety and rich in sources.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0017] Embodiment 1: Preparation of four kinds of diterpene compounds in Wedelia chinensis
[0018] 1.1 Plant source and identification
[0019] The plant material for extraction, Sphagneticola trilobata (L.) Pruski, was collected from the South China Botanical Garden in Guangdong Province in September 2009 and identified by Xing Fuwu, a researcher at the South China Botanical Garden, Chinese Academy of Sciences.
[0020] 1.2 Extraction and separation
[0021] The whole plant of Wedelia chinensis (dry weight 2kg) was pulverized, soaked and extracted with ethanol with a volume fraction of 95% at room temperature for 3 times, each time for 2 days, and the extracts were combined; the ethanol in the extract was drained by concentration under reduced pressure, and then an appropriate amount of water was added to make it It became a suspension, which was extracted 4 times with petroleum ether; the petroleum ether fraction (45 g) was obtained after concentration under reduced pressu...
Embodiment 2
[0026] Embodiment 2: The α-glucosidase inhibitory activity detection of described four kinds of diterpene compounds
[0027] 2.1 Instruments and reagents
[0028] Experimental instrument: Genois microplate reader (Tecan GENios, Swizerland)
[0029] Reagent samples: α-glucosidase was purchased from Sigma Chemical Co. (Sigma-Aldrich, St.Louis, USA); Acarbose was purchased from Tokyo Chemical Industry Co., Ltd. (Japan); Phenylphenol-α-D-glucopyranoside (PNPG) was purchased from Tokyo Chemical Industry Co., Ltd. (Japan); four diterpene compounds α-hydroxy-ent-kauran-19-oic acid (compound 1), 3α-tigloyloxy-9β-hydroxy-ent-kaur-16-en-19-oic acid (compound 2), 3α-cinnamoyloxy-ent-kaur-16-en-19-oic acid (compound 3), 3α-cinnamoyloxy- 9β-hydroxy-ent-kaur-16-en-19-oic acid (compound 4) is prepared from the above experimental example 1 or can also refer to the literature Qiang et al., Helvetica Chimica Acta2011, 94:817-823; Bohlmann et al ., Phytochemistry1981, 20:751-756; Ma et al., N...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com